n,n-dimethyl-n-hexadecyl-1-octadecylammonium has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardo, MCC; Braojo, IMP; Caballero, BB; Carrasco, JM; Fernández, BM; Guerrero, OV; Gutiérrez, ZA; Medina, EAG; Miguel, KL; Montero, YC; Ortiz, MR; Prado, YID; Rodríguez, LEM; Rubio, MC; Torres, KP; Tul, LEA; Varela, IGS | 1 |
| Hata, T; Hiraki, M; Hori, A; Ikeshima, R; Katsuyama, S; Kikumori, K; Masuzawa, T; Mitsuyoshi, A; Murata, K; Ohmura, Y; Oshima, K; Shinke, G; Sugimura, K; Takeda, Y; Yanagawa, T | 1 |
2 other study(ies) available for n,n-dimethyl-n-hexadecyl-1-octadecylammonium and Breast Neoplasms
| Article | Year |
|---|---|
Neoadjuvant Trastuzumab and Pertuzumab in Combination with Standard Chemotherapy for HER2-Positive Early Breast Cancer: Real-World Practice in Cuba.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cuba; Docetaxel; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prospective Studies; Receptor, ErbB-2; Trastuzumab | 2023 |
[A Case of Drug-Induced Interstitial Pneumonia after Dose-Dense AC Therapy].
Topics: Aged; Breast Neoplasms; Doxorubicin; Female; Humans; Lung Diseases, Interstitial; Paclitaxel | 2022 |